Evidence map›Paper›PMID 39322350›Full record

ReviewMagnetic resonance imaging clinics of North America2024

MR Imaging-Guided Focused Ultrasound for Breast Tumors.

Matthew DeWitt, Zehra E F Demir, Thomas Sherlock, David R Brenin, Natasha D Sheybani

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Magnetic resonance imaging clinics of North America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matthew DeWittDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA; Focused Ultrasound Cancer Immunotherapy Center, University of Virginia, Charlottesville, VA, USA.
Zehra E F DemirDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA.
Thomas SherlockDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA.
David R BreninFocused Ultrasound Cancer Immunotherapy Center, University of Virginia, Charlottesville, VA, USA; Division of Surgical Oncology, University of Virginia Health System, Charlottesville, VA, USA.
Natasha D SheybaniDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA; Focused Ultrasound Cancer Immunotherapy Center, University of Virginia, Charlottesville, VA, USA; Department of Radiology & Medical Imaging, University of Virginia, Charlottesville, VA, USA. Electronic address: nds3sa@virginia.edu.

Funding

Cancer Research Training Program: From Molecular Mechanisms to Therapeutic StrategiesT32CA009109 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Andrew Carl Dudley, Melanie R Rutkowski · 1985 to 2026
$13.9M
Immunoengineering Next-Generation Cancer Therapies with Focused UltrasoundDP5OD031846 · OD · UNIVERSITY OF VIRGINIA · PI SHEYBANI, NATASHA DIBA · 2021 to 2025
$2.0M
NCI NIH HHS T32 CA009109NIH HHS DP5 OD031846
6 · The paper itself

Abstract

Breast tumors remain a complex and prevalent health burden impacting millions of individuals worldwide. Challenges in treatment arise from the invasive nature of traditional surgery and, in malignancies, the complexity of treating metastatic disease. The development of noninvasive treatment alternatives is critical for improving patient outcomes and quality of life. This review aims to explore the advancements and applications of focused ultrasound (FUS) technology over the past 2 decades. FUS offers a promising noninvasive, nonionizing intervention strategy in breast tumors including primary breast cancer, fibroadenomas, and metastatic breast cancer.

Indexed as

Breast NeoplasmsMagnetic Resonance Imaging, InterventionalBreastFemaleHigh-Intensity Focused Ultrasound AblationHumansMagnetic Resonance ImagingUltrasonography, InterventionalAblationBreast tumorsCancerFibroadenomaFocused ultrasoundMetastasisMR imaging

Identifiers

PMID39322350
PMCPMC12263100

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.